A new dawn for chronic kidney disease – SGLT-2 inhibition as a novel strategy
VirtualSpeaker: Hermann Haller, M.D., President, MDI Biological Laboratory About the Speaker: Hermann Haller, M.D. an international leader in kidney disease, hypertension and kidney and blood vessel regeneration, was appointed president of the MDI Biological Laboratory on July 26, 2018. Haller has been associated with the MDI Biological Laboratory for over two decades, and has served […]
Free